FL
Frazier Life Sciences Public Fund, L.P. disclosed a 7.4% stake in PHAT
Frazier Life Sciences Public Fund, L.P. reported owning 7.4% of Phathom Pharmaceuticals, Inc. (PHAT) (6,013,327 shares) in a Schedule 13D filed Nov 2, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 2, 2026
- Source
- Schedule 13D